DNA Plasmid Manufacturing Market 2028 By Product Type Plasmid DNA, Application, Technology | The Insight Partners

    DNA Plasmid Manufacturing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (High Quality (HQ) Plasmid DNA, GMP Grade Plasmid DNA, Non-GMP Grade Plasmid DNA); Application (DNA Vaccines, Gene Therapy, Immunotherapy, Others); Technology (Fed-batch Technology, Batch Technology, Continuous Culture Technology)

    Report Code: TIPRE00021640 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

    MARKET INTRODUCTION

    Plasmid (pDNA) DNA plays a significant role in recent healthcare, as it is used instantly as a therapeutic agent in gene therapy or the production of vaccine antigens. Moreover, pDNA is used as a master-template product to encourage new and emerging biopharmaceutical products and processes, including RNA, in-vitro protein production, and cell therapies.

    MARKET DYNAMICS

    The DNA plasmid manufacturing market is driving due to growing awareness of gene therapy and increasing prevalence of genetic disorders and infectious diseases across the world. However, high cost associated with gene therapies will hamper its growth. Moreover, growth of the global healthcare market is expected to provide opportunities in the global DNA plasmid manufacturing market.

    MARKET SCOPE

    The "DNA Plasmid Manufacturing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of DNA plasmid manufacturing market with detailed market segmentation by product type, application, and technology. The DNA plasmid manufacturing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in DNA plasmid manufacturing market and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    The DNA plasmid manufacturing market is segmented based on product type, application, and technology. Based on product type, the market is segmented into high quality (HQ) plasmid DNA, GMP grade plasmid DNA, Non-GMP grade plasmid DNA. Based on application, the market is segmented as DNA vaccines, gene therapy, immunotherapy, others. Based on technology, the market is segmented as fed-batch technology, batch technology, continuous culture technology
    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the DNA plasmid manufacturing market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The DNA plasmid manufacturing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting DNA plasmid manufacturing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the DNA plasmid manufacturing market in these regions.



    Get more information on this report :

    MARKET PLAYERS


    The report covers key developments in the DNA plasmid manufacturing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from DNA plasmid manufacturing market are anticipated to have lucrative growth opportunities in the future with the rising demand for DNA plasmid manufacturing in the global market. Below mentioned is the list of few companies engaged in the DNA plasmid manufacturing market.

    The report also includes the profiles of key players in DNA plasmid manufacturing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

    •   Cobra Biologics & Pharmaceutical Services
    •   VGXI, Inc.
    •   Aldevron
    •   Kaneka Corporation
    •   Nature Application Corporation
    •   Plasmidfactory GMBH & CO. KG
    •   Cell and Gene Therapy Catapult
    •   Waisman Biomanufacturing
    •   Akron Biotech
    •   Vigene Biosciences

    The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 DNA Plasmid Manufacturing Market - By Product Type
    1.3.2 DNA Plasmid Manufacturing Market - By Application
    1.3.3 DNA Plasmid Manufacturing Market - By Technology
    1.3.4 DNA Plasmid Manufacturing Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. DNA PLASMID MANUFACTURING MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. DNA PLASMID MANUFACTURING MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. DNA PLASMID MANUFACTURING MARKET - GLOBAL MARKET ANALYSIS
    6.1. DNA PLASMID MANUFACTURING - GLOBAL MARKET OVERVIEW
    6.2. DNA PLASMID MANUFACTURING - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE
    7. DNA PLASMID MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
    7.1. OVERVIEW
    7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
    7.3. HIGH QUALITY (HQ) PLASMID DNA
    7.3.1. Overview
    7.3.2. High Quality (HQ) Plasmid DNA Market Forecast and Analysis
    7.4. GMP GRADE PLASMID DNA
    7.4.1. Overview
    7.4.2. GMP Grade Plasmid DNA Market Forecast and Analysis
    7.5. NON-GMP GRADE PLASMID DNA
    7.5.1. Overview
    7.5.2. Non-GMP Grade Plasmid DNA Market Forecast and Analysis
    8. DNA PLASMID MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. DNA VACCINES
    8.3.1. Overview
    8.3.2. DNA Vaccines Market Forecast and Analysis
    8.4. GENE THERAPY
    8.4.1. Overview
    8.4.2. Gene Therapy Market Forecast and Analysis
    8.5. IMMUNOTHERAPY
    8.5.1. Overview
    8.5.2. Immunotherapy Market Forecast and Analysis
    8.6. OTHERS
    8.6.1. Overview
    8.6.2. Others Market Forecast and Analysis
    9. DNA PLASMID MANUFACTURING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
    9.1. OVERVIEW
    9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
    9.3. FED-BATCH TECHNOLOGY
    9.3.1. Overview
    9.3.2. Fed-batch Technology Market Forecast and Analysis
    9.4. BATCH TECHNOLOGY
    9.4.1. Overview
    9.4.2. Batch Technology Market Forecast and Analysis
    9.5. CONTINUOUS CULTURE TECHNOLOGY
    9.5.1. Overview
    9.5.2. Continuous Culture Technology Market Forecast and Analysis
    10. DNA PLASMID MANUFACTURING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America DNA Plasmid Manufacturing Market Overview
    10.1.2 North America DNA Plasmid Manufacturing Market Forecasts and Analysis
    10.1.3 North America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Product Type
    10.1.4 North America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Application
    10.1.5 North America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Technology
    10.1.6 North America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Countries
    10.1.6.1 United States DNA Plasmid Manufacturing Market
    10.1.6.1.1 United States DNA Plasmid Manufacturing Market by Product Type
    10.1.6.1.2 United States DNA Plasmid Manufacturing Market by Application
    10.1.6.1.3 United States DNA Plasmid Manufacturing Market by Technology
    10.1.6.2 Canada DNA Plasmid Manufacturing Market
    10.1.6.2.1 Canada DNA Plasmid Manufacturing Market by Product Type
    10.1.6.2.2 Canada DNA Plasmid Manufacturing Market by Application
    10.1.6.2.3 Canada DNA Plasmid Manufacturing Market by Technology
    10.1.6.3 Mexico DNA Plasmid Manufacturing Market
    10.1.6.3.1 Mexico DNA Plasmid Manufacturing Market by Product Type
    10.1.6.3.2 Mexico DNA Plasmid Manufacturing Market by Application
    10.1.6.3.3 Mexico DNA Plasmid Manufacturing Market by Technology
    10.2. EUROPE
    10.2.1 Europe DNA Plasmid Manufacturing Market Overview
    10.2.2 Europe DNA Plasmid Manufacturing Market Forecasts and Analysis
    10.2.3 Europe DNA Plasmid Manufacturing Market Forecasts and Analysis - By Product Type
    10.2.4 Europe DNA Plasmid Manufacturing Market Forecasts and Analysis - By Application
    10.2.5 Europe DNA Plasmid Manufacturing Market Forecasts and Analysis - By Technology
    10.2.6 Europe DNA Plasmid Manufacturing Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany DNA Plasmid Manufacturing Market
    10.2.6.1.1 Germany DNA Plasmid Manufacturing Market by Product Type
    10.2.6.1.2 Germany DNA Plasmid Manufacturing Market by Application
    10.2.6.1.3 Germany DNA Plasmid Manufacturing Market by Technology
    10.2.6.2 France DNA Plasmid Manufacturing Market
    10.2.6.2.1 France DNA Plasmid Manufacturing Market by Product Type
    10.2.6.2.2 France DNA Plasmid Manufacturing Market by Application
    10.2.6.2.3 France DNA Plasmid Manufacturing Market by Technology
    10.2.6.3 Italy DNA Plasmid Manufacturing Market
    10.2.6.3.1 Italy DNA Plasmid Manufacturing Market by Product Type
    10.2.6.3.2 Italy DNA Plasmid Manufacturing Market by Application
    10.2.6.3.3 Italy DNA Plasmid Manufacturing Market by Technology
    10.2.6.4 Spain DNA Plasmid Manufacturing Market
    10.2.6.4.1 Spain DNA Plasmid Manufacturing Market by Product Type
    10.2.6.4.2 Spain DNA Plasmid Manufacturing Market by Application
    10.2.6.4.3 Spain DNA Plasmid Manufacturing Market by Technology
    10.2.6.5 United Kingdom DNA Plasmid Manufacturing Market
    10.2.6.5.1 United Kingdom DNA Plasmid Manufacturing Market by Product Type
    10.2.6.5.2 United Kingdom DNA Plasmid Manufacturing Market by Application
    10.2.6.5.3 United Kingdom DNA Plasmid Manufacturing Market by Technology
    10.2.6.6 Rest of Europe DNA Plasmid Manufacturing Market
    10.2.6.6.1 Rest of Europe DNA Plasmid Manufacturing Market by Product Type
    10.2.6.6.2 Rest of Europe DNA Plasmid Manufacturing Market by Application
    10.2.6.6.3 Rest of Europe DNA Plasmid Manufacturing Market by Technology
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific DNA Plasmid Manufacturing Market Overview
    10.3.2 Asia-Pacific DNA Plasmid Manufacturing Market Forecasts and Analysis
    10.3.3 Asia-Pacific DNA Plasmid Manufacturing Market Forecasts and Analysis - By Product Type
    10.3.4 Asia-Pacific DNA Plasmid Manufacturing Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific DNA Plasmid Manufacturing Market Forecasts and Analysis - By Technology
    10.3.6 Asia-Pacific DNA Plasmid Manufacturing Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia DNA Plasmid Manufacturing Market
    10.3.6.1.1 Australia DNA Plasmid Manufacturing Market by Product Type
    10.3.6.1.2 Australia DNA Plasmid Manufacturing Market by Application
    10.3.6.1.3 Australia DNA Plasmid Manufacturing Market by Technology
    10.3.6.2 China DNA Plasmid Manufacturing Market
    10.3.6.2.1 China DNA Plasmid Manufacturing Market by Product Type
    10.3.6.2.2 China DNA Plasmid Manufacturing Market by Application
    10.3.6.2.3 China DNA Plasmid Manufacturing Market by Technology
    10.3.6.3 India DNA Plasmid Manufacturing Market
    10.3.6.3.1 India DNA Plasmid Manufacturing Market by Product Type
    10.3.6.3.2 India DNA Plasmid Manufacturing Market by Application
    10.3.6.3.3 India DNA Plasmid Manufacturing Market by Technology
    10.3.6.4 Japan DNA Plasmid Manufacturing Market
    10.3.6.4.1 Japan DNA Plasmid Manufacturing Market by Product Type
    10.3.6.4.2 Japan DNA Plasmid Manufacturing Market by Application
    10.3.6.4.3 Japan DNA Plasmid Manufacturing Market by Technology
    10.3.6.5 South Korea DNA Plasmid Manufacturing Market
    10.3.6.5.1 South Korea DNA Plasmid Manufacturing Market by Product Type
    10.3.6.5.2 South Korea DNA Plasmid Manufacturing Market by Application
    10.3.6.5.3 South Korea DNA Plasmid Manufacturing Market by Technology
    10.3.6.6 Rest of Asia-Pacific DNA Plasmid Manufacturing Market
    10.3.6.6.1 Rest of Asia-Pacific DNA Plasmid Manufacturing Market by Product Type
    10.3.6.6.2 Rest of Asia-Pacific DNA Plasmid Manufacturing Market by Application
    10.3.6.6.3 Rest of Asia-Pacific DNA Plasmid Manufacturing Market by Technology
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa DNA Plasmid Manufacturing Market Overview
    10.4.2 Middle East and Africa DNA Plasmid Manufacturing Market Forecasts and Analysis
    10.4.3 Middle East and Africa DNA Plasmid Manufacturing Market Forecasts and Analysis - By Product Type
    10.4.4 Middle East and Africa DNA Plasmid Manufacturing Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa DNA Plasmid Manufacturing Market Forecasts and Analysis - By Technology
    10.4.6 Middle East and Africa DNA Plasmid Manufacturing Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa DNA Plasmid Manufacturing Market
    10.4.6.1.1 South Africa DNA Plasmid Manufacturing Market by Product Type
    10.4.6.1.2 South Africa DNA Plasmid Manufacturing Market by Application
    10.4.6.1.3 South Africa DNA Plasmid Manufacturing Market by Technology
    10.4.6.2 Saudi Arabia DNA Plasmid Manufacturing Market
    10.4.6.2.1 Saudi Arabia DNA Plasmid Manufacturing Market by Product Type
    10.4.6.2.2 Saudi Arabia DNA Plasmid Manufacturing Market by Application
    10.4.6.2.3 Saudi Arabia DNA Plasmid Manufacturing Market by Technology
    10.4.6.3 U.A.E DNA Plasmid Manufacturing Market
    10.4.6.3.1 U.A.E DNA Plasmid Manufacturing Market by Product Type
    10.4.6.3.2 U.A.E DNA Plasmid Manufacturing Market by Application
    10.4.6.3.3 U.A.E DNA Plasmid Manufacturing Market by Technology
    10.4.6.4 Rest of Middle East and Africa DNA Plasmid Manufacturing Market
    10.4.6.4.1 Rest of Middle East and Africa DNA Plasmid Manufacturing Market by Product Type
    10.4.6.4.2 Rest of Middle East and Africa DNA Plasmid Manufacturing Market by Application
    10.4.6.4.3 Rest of Middle East and Africa DNA Plasmid Manufacturing Market by Technology
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America DNA Plasmid Manufacturing Market Overview
    10.5.2 South and Central America DNA Plasmid Manufacturing Market Forecasts and Analysis
    10.5.3 South and Central America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Product Type
    10.5.4 South and Central America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Application
    10.5.5 South and Central America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Technology
    10.5.6 South and Central America DNA Plasmid Manufacturing Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil DNA Plasmid Manufacturing Market
    10.5.6.1.1 Brazil DNA Plasmid Manufacturing Market by Product Type
    10.5.6.1.2 Brazil DNA Plasmid Manufacturing Market by Application
    10.5.6.1.3 Brazil DNA Plasmid Manufacturing Market by Technology
    10.5.6.2 Argentina DNA Plasmid Manufacturing Market
    10.5.6.2.1 Argentina DNA Plasmid Manufacturing Market by Product Type
    10.5.6.2.2 Argentina DNA Plasmid Manufacturing Market by Application
    10.5.6.2.3 Argentina DNA Plasmid Manufacturing Market by Technology
    10.5.6.3 Rest of South and Central America DNA Plasmid Manufacturing Market
    10.5.6.3.1 Rest of South and Central America DNA Plasmid Manufacturing Market by Product Type
    10.5.6.3.2 Rest of South and Central America DNA Plasmid Manufacturing Market by Application
    10.5.6.3.3 Rest of South and Central America DNA Plasmid Manufacturing Market by Technology
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DNA PLASMID MANUFACTURING MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. DNA PLASMID MANUFACTURING MARKET, KEY COMPANY PROFILES
    13.1. COBRA BIOLOGICS AND PHARMACEUTICAL SERVICES
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. VGXI, INC.
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. ALDEVRON
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. KANEKA CORPORATION
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. NATURE APPLICATION CORPORATION
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. PLASMIDFACTORY GMBH AND CO. KG
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. CELL AND GENE THERAPY CATAPULT
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. WAISMAN BIOMANUFACTURING
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. AKRON BIOTECH
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. VIGENE BIOSCIENCES
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    1. Cobra Biologics and Pharmaceutical Services
    2. VGXI, Inc.
    3. Aldevron
    4. Kaneka Corporation
    5. Nature Application Corporation
    6. Plasmidfactory GMBH & CO. KG
    7. Cell and Gene Therapy Catapult
    8. Waisman Biomanufacturing
    9. Akron Biotech
    10. Vigene Biosciences
    11. Brammer Bio
    12. Sanofi
    13. FUJIFILM Diosynth Biotechnologies
    14. MassBiologics
    15. Spark Therapeutics
    16. Uniqure
    17. FinVector
    18. LakePharma, Inc.
    19. Richter-Helm BioLogics
    20. Eurogentec
    TIPRE00021640
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount